Implementation of primary angioplasty in Europe: Stent for Life initiative progress report

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F12%3A43896701" target="_blank" >RIV/00216208:11120/12:43896701 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064173:_____/12:43896701

Výsledek na webu

<a href="http://dx.doi.org/10.4244/EIJV8I1A7" target="_blank" >http://dx.doi.org/10.4244/EIJV8I1A7</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.4244/EIJV8I1A7" target="_blank" >10.4244/EIJV8I1A7</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Implementation of primary angioplasty in Europe: Stent for Life initiative progress report

Popis výsledku v původním jazyce

Primary percutaneous coronary intervention (PPCI) is the recommended treatment for patients with acute ST-segment elevation myocardial infarction (STEMI). Despite substantial evidence of its effectiveness, a 2007 study reported that only 40-45% of European STEMI patients were treated with PPCI, with large variations in treatment availability between countries. In 2008, the Stem for Life (SFL) initiative was launched by the European Association of Percutaneous Cardiovascular Interventions and EuroPCR inpartnership with the European Society of Cardiology (ESC) Working Group on Acute Cardiac Care and country-specific national cardiac societies. The aim is to promote the prioritisation of percutaneous coronary intervention treatment towards those who willbenefit most, namely STEMI patients. The following countries are currently participating: Bulgaria, Egypt, France, Greece, Italy, Portugal, Romania, Serbia, Spain and Turkey. Methods and results: Since SFL was launched, several activitie

Název v anglickém jazyce

Implementation of primary angioplasty in Europe: Stent for Life initiative progress report

Popis výsledku anglicky

Primary percutaneous coronary intervention (PPCI) is the recommended treatment for patients with acute ST-segment elevation myocardial infarction (STEMI). Despite substantial evidence of its effectiveness, a 2007 study reported that only 40-45% of European STEMI patients were treated with PPCI, with large variations in treatment availability between countries. In 2008, the Stem for Life (SFL) initiative was launched by the European Association of Percutaneous Cardiovascular Interventions and EuroPCR inpartnership with the European Society of Cardiology (ESC) Working Group on Acute Cardiac Care and country-specific national cardiac societies. The aim is to promote the prioritisation of percutaneous coronary intervention treatment towards those who willbenefit most, namely STEMI patients. The following countries are currently participating: Bulgaria, Egypt, France, Greece, Italy, Portugal, Romania, Serbia, Spain and Turkey. Methods and results: Since SFL was launched, several activitie

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

EuroIntervention

ISSN

1774-024X

e-ISSN

—

Svazek periodika

8

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

FR - Francouzská republika

Počet stran výsledku

8

Strana od-do

35-42

Kód UT WoS článku

000305593300007

EID výsledku v databázi Scopus

—